Adrenal androgen excess in hyperandrogenism: relation to age and body mass
- PMID: 10202877
- DOI: 10.1016/s0015-0282(98)00536-6
Adrenal androgen excess in hyperandrogenism: relation to age and body mass
Abstract
Objective: To determine whether DHEAS levels in hyperandrogenic (HA) women retain the normal age-related decrease.
Design: Prospective study.
Setting: Academic tertiary care medical center.
Patient(s): One hundred forty-five HA patients with hirsutism and/or oligo-ovulation and 53 healthy women.
Intervention(s): Blood samples were obtained on days 3-8 of the menstrual cycle or after an IM progesterone-induced withdrawal bleed.
Main outcome measure(s): Serum samples were assayed for progesterone, total testosterone, sex hormone-binding globulin, free testosterone, and DHEAS.
Result(s): Controls and HA patients were similar in body mass index and age. A negative correlation between DHEAS levels and age, but not body mass index, was found among controls. In HA patients. DHEAS levels decreased with age. Dehydroepiandrosterone sulfate levels correlated with the hirsutism score in HA patients. When HA patients were subdivided into those with low, middle, and high DHEAS levels, those with low DHEAS levels were older and weighed more than those with high DHEAS levels.
Conclusion(s): The negative association between DHEAS levels and age is preserved in HA women. Hyperandrogenic patients with high DHEAS levels are younger, thinner, and more hirsute than those with lower DHEAS levels. These findings suggest that the diagnosis of adrenal androgen excess in HA patients may require the use of age-adjusted normative values.
Similar articles
-
Menstrual dysfunction in polycystic ovary syndrome: association with dynamic state insulin resistance rather than hyperandrogenism.Fertil Steril. 2021 Jun;115(6):1557-1568. doi: 10.1016/j.fertnstert.2020.12.015. Epub 2021 Feb 15. Fertil Steril. 2021. PMID: 33602559 Free PMC article.
-
Ovulation after glucocorticoid suppression of adrenal androgens in the polycystic ovary syndrome is not predicted by the basal dehydroepiandrosterone sulfate level.J Clin Endocrinol Metab. 1999 Mar;84(3):946-50. doi: 10.1210/jcem.84.3.5574. J Clin Endocrinol Metab. 1999. PMID: 10084576 Clinical Trial.
-
Heterogenous origins of hyperandrogenism in the polycystic ovary syndrome in relation to body mass index and insulin resistance.Gynecol Endocrinol. 2018 Mar;34(3):238-242. doi: 10.1080/09513590.2017.1393062. Epub 2017 Oct 25. Gynecol Endocrinol. 2018. PMID: 29068242
-
DHEA, DHEAS and PCOS.J Steroid Biochem Mol Biol. 2015 Jan;145:213-25. doi: 10.1016/j.jsbmb.2014.06.003. Epub 2014 Jul 5. J Steroid Biochem Mol Biol. 2015. PMID: 25008465 Review.
-
Hyperandrogenism after menopause: diagnostic evaluation.Climacteric. 2025 Feb;28(1):61-68. doi: 10.1080/13697137.2024.2423874. Epub 2024 Nov 14. Climacteric. 2025. PMID: 39540243 Review.
Cited by
-
Adrenal Androgen Predictive Effects on Clinical and Metabolic Abnormalities of Polycystic Ovary Syndrome.Rev Bras Ginecol Obstet. 2022 Feb;44(2):142-153. doi: 10.1055/s-0041-1741030. Epub 2022 Feb 25. Rev Bras Ginecol Obstet. 2022. PMID: 35213912 Free PMC article.
-
Association of obesity and overweight with the prevalence of insulin resistance, pre-diabetes and clinical-biochemical characteristics among infertile Mexican women with polycystic ovary syndrome: a cross-sectional study.BMJ Open. 2016 Jul 22;6(7):e012107. doi: 10.1136/bmjopen-2016-012107. BMJ Open. 2016. PMID: 27449893 Free PMC article.
-
A rare case of pure testosterone-secreting adrenal adenoma in a postmenopausal elderly woman.BMC Endocr Disord. 2019 Jan 23;19(1):14. doi: 10.1186/s12902-019-0342-y. BMC Endocr Disord. 2019. PMID: 30674304 Free PMC article.
-
Increased Prevalence of Elevated DHEAS in PCOS Women with Non-Classic (B or C) Phenotypes: A Retrospective Analysis in Patients Aged 20 to 29 Years.Cells. 2022 Oct 17;11(20):3255. doi: 10.3390/cells11203255. Cells. 2022. PMID: 36291122 Free PMC article.
-
Metabolic profiling reveals reprogramming of lipid metabolic pathways in treatment of polycystic ovary syndrome with 3-iodothyronamine.Physiol Rep. 2017 Jan;5(1):e13097. doi: 10.14814/phy2.13097. Physiol Rep. 2017. PMID: 28082426 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical